The search terms included “interstitial lung disease”, “pneumonitis”, “novel antineoplastic agents”, “breast cancer”, “tyrosine kinase inhibitors”, “monoclonal antibodies”, “antibody-drug conjugates”, “immune checkpoint inhibitors”, “CDK4/6 inhibitors”, “PARP inhibitors” and “PI3K/AKT/mTOR inhibitors”. This evidence concerns the gene CDK4 and interstitial lung disease.